The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 60%. Insiders have been net buyers over the past quarter.
Elevra Lithium Limited
ELVR · Nasdaq · USD · Market cap $470M · 230 employees
Elevra Lithium Limited, together with its subsidiaries, engages in the identification, acquisition, exploration, and development of mineral assets in Australia and Canada.
PASS · Titan Ethical · score 70.0Price as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price24.87 USD at the 13 Nov 2026 close
- Fair value12.44. Our model only; no analyst estimate to cross-check.
- Our value readOvervalued vs our fair value, as of 13 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available, base estimate $12.44 (screen dated 2026-11-13).
- Trend Distribution
- Insiders insiders bought, latest filing 2026-10-28
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Elevra Lithium Limited holds its Distribution at $24.87. The statistical read favours the buyers, held for 85 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 85 days |
| Price at the screen | $24.87 |
| Valuation | 9.04 trailing · 346.29 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.06 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 18.19% | Below 33% | Interest-bearing debt is just 18.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 14.61% | Below 49% | Money owed to the company is 14.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.92% | Below 5% | Only 1.9% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Elevra Lithium clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ELVR's ethical verdict changes
Today ELVR passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our model only; no analyst estimate to cross-check.
Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $12.44 fair value estimate, 77.50% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 99.9% above the base estimate.
Where our models see it going: fair-value estimate $12.44, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsLithium dreams priced far beyond reality
Picture a junior miner hunting lithium in remote Australian and Canadian ground while burning cash at every step. Elevra trades at sixty dollars against a fair value of thirty, a margin of safety that sits at minus fifty percent. Forward earnings sit at eight hundred fifty times, revenue edges up only eight percent, and both profit margins and return on equity remain deeply negative. Ethical checks clear, yet the numbers show a business that has yet to prove it can deliver consistent profits in a notoriously volatile sector.
We pass for the straightforward reason that the price already prices in far more success than the current results support. Unknown competitive edge and a forward multiple this stretched leave little room for the usual exploration disappointments that hit these projects. In cyclical metals the trap is classic: peak commodity sentiment meets stretched valuations and investors discover the low point in earnings still lies ahead.
Lithium prices swing hard with battery demand and new supply, turning apparently cheap entries into permanent capital losses when cycles turn. Analysis, not advice.
| Forward P/E | 346.3xexpensive even after accounting for its growth |
| Trailing P/E | 9.0xvery cheap relative to earnings |
| EPS, trailing | 2.68 |
| EPS, forward | 0.07 |
| Revenue growth | +77.5%growing very fast |
| Profit margin | 21.3%healthy profit margins |
| Return on equity | 8.6%a modest return on shareholder capital |
| FCF yield | -11.95% |
| Debt to equity | 0.11minimal debt: a conservative balance sheet |
| Current ratio | 3.44comfortably covers its short-term bills |
| Beta | 1.06moves a little more than the market |
| 52-week range | 21.32 - 102.80 |
| Market cap | $470M |
| Employees | 230 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Australia and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeELVR trades on Nasdaq (the company is based in Australia). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 60%. Insiders have been net buyers over the past quarter.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Our forward projection puts the odds of a 10% gain over the next month near 60%.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 38.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 60%.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 26.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 60%. Since the last review it its composite score rose.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 60%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 28.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 60%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 60%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Atantic Lithium moves closer to takeover completion Yahoo Finance · 20d ago
- What Elevra Lithium (ELVR) Said on Its Q1 Earnings Call Yahoo Finance · 20d ago
- Elevra Lithium Quarterly Activities Report Yahoo Finance · 20d ago
- Elevra Lithium Completes Sale of Ewoyaa Project Interest Yahoo Finance · 21d ago
- Elevra Lithium Limited Q1 2027 Earnings Call Summary Yahoo Finance · 21d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-28 | Cortes Vargas Christian Mauricio | CFO | P - Purchase | 16,000 | $42,720 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $97.81 | -25.6% | · | $744 | -25.6% |
| 2 months | $62.41 | +16.7% | · | $1,167 | +16.7% |
| 3 months | $52.08 | +39.8% | · | $1,398 | +39.8% |
| 6 months | $44.63 | +63.1% | · | $1,631 | +63.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ELVR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.